Why Ovarian Cancer Is Often Diagnosed Later in Black Women

Symptoms of ovarian cancer can be subtle, easily mistaken for everyday health concerns, or overlooked altogether. For many Black women, this reality contributes to a troubling pattern of ovarian cancer being diagnosed at later stages. When this happens, treatment options may be more limited and outcomes less favorable.

Understanding why this happens and knowing what to look for can help shift the narrative toward increased awareness and informed care.

Eli Lilly and Company is conducting a two-part clinical trial (Part A and B) testing a potential new medicine for people with certain types of ovarian cancer. Part A looks at participants whose cancer no longer responds to platinum-based treatments. Part B looks at participants whose cancer still responds to platinum-based treatments. Click here to learn more.

Disparities in Ovarian Cancer

Research shows that Black women are more likely to experience poor outcomes related to ovarian cancer overall. These disparities are not the result of biology alone. They are shaped by a combination of systemic barriers, gaps in awareness, and differences in access to timely diagnosis and specialized care.

Early symptoms of ovarian cancer are vague and can overlap with common conditions such as digestive issues, menstrual changes, or stress-related discomfort. When symptoms are misunderstood or minimized, diagnosis may be delayed.

For Black women, these delays may be complicated by:

• Limited access to consistent gynecologic care
• Symptoms being dismissed or attributed to other chronic conditions
• Underrepresentation in clinical research

Raising awareness of these realities is a critical step toward improving outcomes.

Symptoms That Are Easy to Miss

Unlike some cancers that present with clear warning signs, ovarian cancer symptoms often develop gradually. They may seem mild at first, come and go, or feel unrelated to the reproductive system. This can make it harder to know when something warrants further evaluation.

Symptoms may include:

• Persistent bloating or abdominal swelling
• Pelvic or abdominal pain
• Feeling full quickly or difficulty eating
• Changes in bowel or bladder habits, such as urgency or frequency
• Unexplained fatigue or back pain

What matters most is not the presence of one symptom, but whether symptoms are new, persistent, and represent a change from what is normal. When symptoms last for weeks rather than days, it may be time to ask more questions.

Listening to and trusting your body can make a meaningful difference.

Why Later Diagnosis Impacts Outcomes

When ovarian cancer is diagnosed at a later stage, it has often spread beyond the ovaries. This can affect treatment decisions and response to therapy. Some people may initially respond to platinum-based chemotherapy (platinum-sensitive ovarian cancer, or PSOC), while others may see the cancer return or stop responding over time (platinum-resistant ovarian cancer, or PROC).

Both PSOC and PROC present unique challenges, and ongoing research is essential to better understand how to treat these diseases more effectively across diverse populations.

The Role of Clinical Research Studies

Clinical research studies play an important role in advancing ovarian cancer care. They help researchers explore new treatment approaches, combinations, and strategies that may lead to better outcomes. This is especially important for people with limited options, such as those living with recurrent or treatment-resistant disease.

Considering a clinical research study does not mean giving up standard treatment. Many research studies are designed to compare promising new approaches with current standards of care, while closely monitoring safety at every step.

Moving Forward With Knowledge and Support

Knowing the symptoms, understanding the disparities, and being aware of all available options can empower Black women and their families to advocate for timely care.
If you or someone you love has been affected by ovarian cancer, learning about clinical research studies opportunities may be an important part of the conversation.
To explore ongoing ovarian cancer clinical research studies and see if a study may be right for you, visit Lilly’s clinical research studies guide and pre-screener here.
Early awareness, informed choices, and inclusive research can help rewrite the story of future ovarian cancer outcomes.